These studies have shown that loss of Shh expression invariably accompanies progression to invasive carcinoma and that suppression of the Hh response in the tumor stroma significantly accelerates the initiation of cancer, suggesting that Hh pathway activity protects against tumor progression at early stages of tumor development. This evidence concerns the gene SHH and cancer.